TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Research Report 2023

Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Research Report 2023

  • Category:Life Sciences
  • Published on : 13 December 2022
  • Pages :90
  • Formats:
  • Report Code:SMR-7507547
OfferClick for best price

Best Price: $2320

Nonsteroidal AntiInflammatory Drugs NSAIDs Market Size, Share 2022


Market Analysis and Insights: Global Nonsteroidal AntiInflammatory Drugs NSAIDs Market

The global Nonsteroidal AntiInflammatory Drugs NSAIDs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nonsteroidal AntiInflammatory Drugs NSAIDs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nonsteroidal AntiInflammatory Drugs NSAIDs market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nonsteroidal AntiInflammatory Drugs NSAIDs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nonsteroidal AntiInflammatory Drugs NSAIDs market.

Global Nonsteroidal AntiInflammatory Drugs NSAIDs Scope and Market Size

Market Analysis and Insights: Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market

Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and kidney disease.

The global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market size is projected to reach US$ million by 2030, from US$ million in 2022, at a CAGR of % during 2023-2030.

North America dominated the global NSAID API market due to high demand for APIs in drug formulations and research and development programs in this region. The region is expected to continue its dominance in the coming years owing to increasing preference for generic medicines as a result of high healthcare costs in the U.S. Among other regions, Asia-Pacific is the next largest market for APIs. This region has become the most attractive market due to clustering of a large number of generic medicine manufacturers.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market.

Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Scope and Market Size

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2030.

Segment by Type

Paracetamol

Ibuprofen

Aspirin

Naproxen

Others

Segment by Application

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

By Company

Novartis

Pfizer

Boehringer Ingelheim

Teva Pharmaceutical

Hospira

Lonza Group

Mylan

Aurobindo Pharma

Dr. Reddy's Laboratories

Actavis

Wuxi Apptec

Zhejiang NHU

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Nonsteroidal AntiInflammatory Drugs NSAIDs product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Nonsteroidal AntiInflammatory Drugs NSAIDs, with price, sales, revenue, and global market share of Nonsteroidal AntiInflammatory Drugs NSAIDs from 2019 to 2022.

Chapter 3, the Nonsteroidal AntiInflammatory Drugs NSAIDs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Nonsteroidal AntiInflammatory Drugs NSAIDs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Nonsteroidal AntiInflammatory Drugs NSAIDs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Nonsteroidal AntiInflammatory Drugs NSAIDs.

Chapter 13, 14, and 15, to describe Nonsteroidal AntiInflammatory Drugs NSAIDs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Nonsteroidal AntiInflammatory Drugs NSAIDs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Research Report 2023
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 90 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type: 2017 VS 2022 VS 2030
1.2.2 Paracetamol
1.2.3 Ibuprofen
1.2.4 Aspirin
1.2.5 Naproxen
1.2.6 Others
1.3 Market by Application
1.3.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application: 2017 VS 2022 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Perspective (2017-2030)
2.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Growth Trends by Region
2.2.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region: 2017 VS 2022 VS 2030
2.2.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Region (2017-2023)
2.2.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Region (2023-2030)
2.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Dynamics
2.3.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry Trends
2.3.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers
2.3.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Challenges
2.3.4 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players by Revenue
3.1.1 Global Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players by Revenue (2017-2023)
3.1.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Players (2017-2023)
3.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue
3.4 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio
3.4.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2022
3.5 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players Head office and Area Served
3.6 Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Solution and Service
3.7 Date of Enter into Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Breakdown Data by Type
4.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Type (2017-2023)
4.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Type (2023-2030)
5 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Breakdown Data by Application
5.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Application (2017-2023)
5.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Application (2023-2030)
6 North America
6.1 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2017-2030)
6.2 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2023)
6.3 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2023-2030)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2017-2030)
7.2 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2023)
7.3 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2023-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2017-2030)
8.2 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2023)
8.3 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2023-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2017-2030)
9.2 Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2023)
9.3 Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2023-2030)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2017-2030)
10.2 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2023)
10.3 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2023-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.1.4 Novartis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2023)
11.1.5 Novartis Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.2.4 Pfizer Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2023)
11.2.5 Pfizer Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Detail
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.3.4 Boehringer Ingelheim Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2023)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Teva Pharmaceutical
11.4.1 Teva Pharmaceutical Company Detail
11.4.2 Teva Pharmaceutical Business Overview
11.4.3 Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.4.4 Teva Pharmaceutical Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2023)
11.4.5 Teva Pharmaceutical Recent Development
11.5 Hospira
11.5.1 Hospira Company Detail
11.5.2 Hospira Business Overview
11.5.3 Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.5.4 Hospira Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2023)
11.5.5 Hospira Recent Development
11.6 Lonza Group
11.6.1 Lonza Group Company Detail
11.6.2 Lonza Group Business Overview
11.6.3 Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.6.4 Lonza Group Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2023)
11.6.5 Lonza Group Recent Development
11.7 Mylan
11.7.1 Mylan Company Detail
11.7.2 Mylan Business Overview
11.7.3 Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.7.4 Mylan Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2023)
11.7.5 Mylan Recent Development
11.8 Aurobindo Pharma
11.8.1 Aurobindo Pharma Company Detail
11.8.2 Aurobindo Pharma Business Overview
11.8.3 Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.8.4 Aurobindo Pharma Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2023)
11.8.5 Aurobindo Pharma Recent Development
11.9 Dr. Reddy's Laboratories
11.9.1 Dr. Reddy's Laboratories Company Detail
11.9.2 Dr. Reddy's Laboratories Business Overview
11.9.3 Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.9.4 Dr. Reddy's Laboratories Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2023)
11.9.5 Dr. Reddy's Laboratories Recent Development
11.10 Actavis
11.10.1 Actavis Company Detail
11.10.2 Actavis Business Overview
11.10.3 Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.10.4 Actavis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2023)
11.10.5 Actavis Recent Development
11.11 Wuxi Apptec
11.11.1 Wuxi Apptec Company Detail
11.11.2 Wuxi Apptec Business Overview
11.11.3 Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.11.4 Wuxi Apptec Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2023)
11.11.5 Wuxi Apptec Recent Development
11.12 Zhejiang NHU
11.12.1 Zhejiang NHU Company Detail
11.12.2 Zhejiang NHU Business Overview
11.12.3 Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.12.4 Zhejiang NHU Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2023)
11.12.5 Zhejiang NHU Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type (US$ Million): 2017 VS 2022 VS 2030
Table 2. Key Players of Paracetamol
Table 3. Key Players of Ibuprofen
Table 4. Key Players of Aspirin
Table 5. Key Players of Naproxen
Table 6. Key Players of Others
Table 7. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth by Application (US$ Million): 2017 VS 2022 VS 2030
Table 8. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (US$ Million): 2017 VS 2022 VS 2030
Table 9. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2017-2023) & (US$ Million)
Table 10. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region (2017-2023)
Table 11. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Region (2023-2030) & (US$ Million)
Table 12. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region (2023-2030)
Table 13. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Trends
Table 14. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers
Table 15. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Challenges
Table 16. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints
Table 17. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players (2017-2023) & (US$ Million)
Table 18. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Players (2017-2023)
Table 19. Global Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) as of 2022)
Table 20. Ranking of Global Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (CR5 and HHI) & (2017-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Solution and Service
Table 24. Date of Enter into Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2017-2023) & (US$ Million)
Table 27. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2017-2023)
Table 28. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Type (2023-2030) & (US$ Million)
Table 29. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2023-2030)
Table 30. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2017-2023) & (US$ Million)
Table 31. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application (2017-2023)
Table 32. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Application (2023-2030) & (US$ Million)
Table 33. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application (2023-2030)
Table 34. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2023) & (US$ Million)
Table 35. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2023-2030) & (US$ Million)
Table 36. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2023) & (US$ Million)
Table 37. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2023-2030) & (US$ Million)
Table 38. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2017-2023) & (US$ Million)
Table 39. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2023-2030) & (US$ Million)
Table 40. Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2023) & (US$ Million)
Table 41. Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2023-2030) & (US$ Million)
Table 42. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2023) & (US$ Million)
Table 43. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2023-2030) & (US$ Million)
Table 44. Novartis Company Detail
Table 45. Novartis Business Overview
Table 46. Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 47. Novartis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2023) & (US$ Million)
Table 48. Novartis Recent Development
Table 49. Pfizer Company Detail
Table 50. Pfizer Business Overview
Table 51. Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 52. Pfizer Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2023) & (US$ Million)
Table 53. Pfizer Recent Development
Table 54. Boehringer Ingelheim Company Detail
Table 55. Boehringer Ingelheim Business Overview
Table 56. Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 57. Boehringer Ingelheim Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2023) & (US$ Million)
Table 58. Boehringer Ingelheim Recent Development
Table 59. Teva Pharmaceutical Company Detail
Table 60. Teva Pharmaceutical Business Overview
Table 61. Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 62. Teva Pharmaceutical Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2023) & (US$ Million)
Table 63. Teva Pharmaceutical Recent Development
Table 64. Hospira Company Detail
Table 65. Hospira Business Overview
Table 66. Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 67. Hospira Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2023) & (US$ Million)
Table 68. Hospira Recent Development
Table 69. Lonza Group Company Detail
Table 70. Lonza Group Business Overview
Table 71. Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 72. Lonza Group Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2023) & (US$ Million)
Table 73. Lonza Group Recent Development
Table 74. Mylan Company Detail
Table 75. Mylan Business Overview
Table 76. Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 77. Mylan Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2023) & (US$ Million)
Table 78. Mylan Recent Development
Table 79. Aurobindo Pharma Company Detail
Table 80. Aurobindo Pharma Business Overview
Table 81. Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 82. Aurobindo Pharma Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2023) & (US$ Million)
Table 83. Aurobindo Pharma Recent Development
Table 84. Dr. Reddy's Laboratories Company Detail
Table 85. Dr. Reddy's Laboratories Business Overview
Table 86. Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 87. Dr. Reddy's Laboratories Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2023) & (US$ Million)
Table 88. Dr. Reddy's Laboratories Recent Development
Table 89. Actavis Company Detail
Table 90. Actavis Business Overview
Table 91. Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 92. Actavis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2023) & (US$ Million)
Table 93. Actavis Recent Development
Table 94. Wuxi Apptec Company Detail
Table 95. Wuxi Apptec Business Overview
Table 96. Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)Product
Table 97. Wuxi Apptec Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2023) & (US$ Million)
Table 98. Wuxi Apptec Recent Development
Table 99. Zhejiang NHU Company Detail
Table 100. Zhejiang NHU Business Overview
Table 101. Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)Product
Table 102. Zhejiang NHU Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2023) & (US$ Million)
Table 103. Zhejiang NHU Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type: 2022 VS 2030
Figure 2. Paracetamol Features
Figure 3. Ibuprofen Features
Figure 4. Aspirin Features
Figure 5. Naproxen Features
Figure 6. Others Features
Figure 7. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application in 2022 & 2030
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Report Years Considered
Figure 12. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (US$ Million), Year-over-Year: 2017-2030
Figure 13. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, (US$ Million), 2017 VS 2022 VS 2030
Figure 14. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region: 2022 VS 2030
Figure 15. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Players in 2022
Figure 16. Global Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2022
Figure 18. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 19. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2017-2030)
Figure 20. United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 21. Canada Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 22. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 23. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2017-2030)
Figure 24. Germany Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 25. France Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 26. U.K. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 27. Italy Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 28. Russia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 29. Nordic Countries Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 30. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 31. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region (2017-2030)
Figure 32. China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 33. Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 34. South Korea Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 35. Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 36. India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 37. Australia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 38. Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 39. Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2017-2030)
Figure 40. Mexico Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 41. Brazil Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 42. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 43. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2017-2030)
Figure 44. Turkey Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 45. Saudi Arabia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 46. Novartis Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2023)
Figure 47. Pfizer Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2023)
Figure 48. Boehringer Ingelheim Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2023)
Figure 49. Teva Pharmaceutical Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2023)
Figure 50. Hospira Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2023)
Figure 51. Lonza Group Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2023)
Figure 52. Mylan Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2023)
Figure 53. Aurobindo Pharma Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2023)
Figure 54. Dr. Reddy's Laboratories Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2023)
Figure 55. Actavis Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2023)
Figure 56. Wuxi Apptec Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2023)
Figure 57. Zhejiang NHU Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount